Targeted Lipid Nanoparticle Delivery via Antibody Conjugation and Mutant ApoE-Based Precoating Strategies
Invention type: Technology
/
Case number: #26557
Researchers
Omar Abudayyeh
/
Alisan Kayabolen
/
Cian Schmitt-Ulms
/
Jonathan S. Gootenberg
Departments: Brain and Cognitive Sciences
Technology Areas: Biotechnology: Biomanufacturing, Synthetic Biology / Drug Delivery: Microparticles & Nanoparticles / Therapeutics: Nucleic Acids, Proteins & Antibodies
Impact Areas: Healthy Living
-
targeted lipid nanoparticle delivery via antibody conjugation and mutant apoe-based precoating strategies
United States of America | Pending
License this technology
Interested in this technology? Connect with our experienced licensing team to initiate the process.
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.